2026 Diabetes Technology Meeting
Kinexum Founder and Executive Chairman Dr. Zan Fleming will participate in an expert consensus meeting, CGM to Diagnose Diabetes, on October 26, 2026, immediately preceding the annual Diabetes Technology Meeting (DTM) in Arlington, Virginia. As continuous glucose monitoring (CGM) technologies continue to advance, an important question is emerging: Can CGM evolve from a tool for disease […]
Translational Research Methods for the Metabolic Continuum Available for Preorder
The third edition of Translational Research Methods for the Metabolic Continuum: A Focus on Early Phase Clinical Drug Development is now available for pre-order! An invaluable resource for translational scientists, clinicians, and drug developers, Translational Research Methods provides practical insights into the evolving strategies shaping the future of early-phase drug development. The book describes the growing […]
2025 Dietary Guidelines: A Major Step Forward With Troubling Flaws
Part 1 Every five years, the USDA and HHS release the Dietary Guidelines for Americans (DGAs). These are supposed to represent a consensus of the best current scientific thinking about what constitutes an optimal diet. They also have real policy implications, as they dictate school lunch programs, military rations, and nutrition assistance programs, effectively shaping […]
Wow! or Yeow?! 2026 Recap
Kinexum’s 9th annual Wow! or Yeow?! FDA Year in Review and a Look Ahead was streamed on January 30, 2026. Zan Fleming, founder and executive chairman of Kinexum and former Supervisory Physician at FDA, moderated the panel. The session opened with David Fox, partner at Hogan Lovells and former FDA Associate Chief Counsel, who provided […]